Uncoupling the TFIIH Core and Kinase Modules Leads To Unregulated RNA Polymerase II CTD Serine 5 Phosphorylation.


Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
12 Sep 2023
Historique:
pubmed: 25 9 2023
medline: 25 9 2023
entrez: 25 9 2023
Statut: epublish

Résumé

TFIIH is an essential transcription initiation factor for RNA polymerase II (RNApII). This multi-subunit complex comprises two modules that are physically linked by the subunit Tfb3 (MAT1 in metazoans). The TFIIH Core Module, with two DNA-dependent ATPases and several additional subunits, promotes DNA unwinding. The TFIIH Kinase Module phosphorylates Serine 5 of the C-terminal domain (CTD) of RNApII subunit Rpb1, a modification that coordinates exchange of initiation and early elongation factors. While it is not obvious why these two disparate activities are bundled into one factor, the connection may provide temporal coordination during early initiation. Here we show that Tfb3 can be split into two parts to uncouple the TFIIH modules. The resulting cells grow slower than normal, but are viable. Chromatin immunoprecipitation of the split TFIIH shows that the Core Module, but not the Kinase, is properly recruited to promoters. Instead of the normal promoter-proximal peak, high CTD Serine 5 phosphorylation is seen throughout transcribed regions. Therefore, coupling the TFIIH modules is necessary to localize and limit CTD kinase activity to early stages of transcription. These results are consistent with the idea that the two TFIIH modules began as independent functional entities that became connected by Tfb3 during early eukaryotic evolution.

Identifiants

pubmed: 37745343
doi: 10.1101/2023.09.11.557269
pmc: PMC10515806
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM046498
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM056663
Pays : United States

Auteurs

Gabriela Giordano (G)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.

Robin Buratowski (R)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.

Célia Jeronimo (C)

Institut de recherches cliniques de Montréal (IRCM), Montréal, Québec, Canada.

Christian Poitras (C)

Institut de recherches cliniques de Montréal (IRCM), Montréal, Québec, Canada.

François Robert (F)

Institut de recherches cliniques de Montréal (IRCM), Montréal, Québec, Canada.
Département de Médecine, Université de Montréal, Montréal, Québec, Canada.
Division of Experimental Medicine, Medicine, McGill University, Montréal, Québec, Canada.

Stephen Buratowski (S)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.

Classifications MeSH